Biofrontera Inc. (BFRI)
Health Care ยท Pharmaceutical Preparations
Biofrontera Inc. (BFRI) is listed on Nasdaq, where its shares have traded since October 29, 2021. SentiSense covers Biofrontera Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. The company reports 94 employees, and its corporate website is www.biofrontera-us.com.
About Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Latest reported results
Biofrontera Inc. reported revenue of $12.0 million for Q2 FY2026, up 32.9% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 18 institutions reported holding BFRI, with 2.8 million shares worth $2.6 million in aggregate. The largest reported holders were Rosalind Advisors, Aigh Capital Management and Renaissance Technologies. Of the 5 largest reported holders, 2 opened new positions in BFRI, 2 added shares and 1 reduced its position during the quarter.
More on BFRI
- BFRI sentiment: whether news and social coverage of Biofrontera Inc. leans bullish or bearish, and the stories driving it.
- BFRI ownership: all 18 reporting institutions, plus insider and congressional trades.
- BFRI financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
SentiSense also tracks daily options readings for Biofrontera Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Biofrontera Inc. do?
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy.
What sector is BFRI in?
SentiSense classifies Biofrontera Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does BFRI stock trade?
Biofrontera Inc. (BFRI) is listed on Nasdaq, where its shares have traded since October 29, 2021.
How many institutions own BFRI?
18 institutions reported a position in BFRI in 13F filings for the quarter ended June 30, 2026, worth $2.6 million in total.